UN&UP Receives Prestigious NIH Phase II SBIR Award from the NHLBI for its Novel Electrophysiology System
Arrhythmias are a major cause of US mortality with ventricular fibrillation, ventricular tachycardia, and atrial fibrillation resulting in 430,000 annual deaths. Although catheter ablation is a proven treatment option, control of ablation catheters can be complex, resulting in imprecise and unreliable heart-wall contact leading to an increased likelihood of injury and arrhythmia recurrence.
UNandUP (short for “Unmet Needs and Underserved Populations”) is developing an affordable magneto-robotic platform which uses low magnetic fields to overcome limitations related to electrophysiology catheter navigational accuracy, stability, and applied forces.
W'e’re excited to announce UN&UP has received a NIH Phase II SBIR award from the NHLBI to explore a transformative electrophysiology robotic system.
As always, our research partners include key opinion leaders from Washington University, University of Pittsburgh Medical Center, and NHMFL/MagCorp.
We would like to thank BioGenerator and Bio STL for supporting this effort.